Britain will start vaccinating people against COVID-19 with the Pfizer vaccine next week after the country's regulator approved the jab on Wednesday, health minister Matt Hancock said on Wednesday.
"From early next week we will start a programme of vaccinating people against COVID-19 here in this country," he told Sky News, calling it "fantastic news".
With this, the UK became the first country in the world to approve the Pfizer-BioNTech COVID-19 vaccine
Meanwhile, India's COVID-19 caseload rose to 94.99 lakh, while the total number of people who have recuperated from the disease crossed 89 lakh pushing the national recovery rate to over 94 per cent, according to the Union Health Ministry data updated on Wednesday.
The total coronavirus cases mounted to 94,99,413, with 36,604 new infections being reported in a day, while the death count climbed to 1,38,122 with 501 new fatalities, the data updated at 8 am showed.
The number of people who have recuperated from the disease surged to 89,32,647 pushing the national recovery rate to 94.03 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.
The active COVID-19 caseload remained below 5 lakh for the 22nd consecutive day. There are 4,28,644 active coronavirus infections in the country which comprises 4.51 per cent of the total caseload, the data stated.
Here are the Highlights on India Coronavirus Cases:
Punjab: Police check vehicles of commuters in Amritsar as night curfew has been imposed in all towns and cities of the state from 10 pm to 5 am, with effect from December 1. #COVID19 pic.twitter.com/v9BMBicQki
- ANI (@ANI) December 2, 2020
The Gujarat High Court on Wednesday ordered compulsory community service at COVID-19 care centres for those who do not wear masks, which according to experts is necessary to prevent the spread of the virus.
A bench of Chief Justice Vikram Nath and Justice JB Pardiwala directed the state government to issue a notification mandating community service at COVID care centres for those found in violations of the rules for wear face masks at public places.
Britain's Prime Minister Boris Johnson on Wednesday hailed UK approval for the use of Pfizer-BioNTech's Covid-19 vaccine as "fantastic" news that would help life get back to normal.
"It's the protection of vaccines that will ultimately allow us to reclaim our lives and get the economy moving again," he said, after regulators gave the green light in a world first.
Britain's approval of BioNTech-Pfizer's vaccine against Covid-19 marks a "historic moment" in the battle against the pandemic, the US pharma group's chief executive said Wednesday, after his company won the first such authorisation in the West.
"Today's Emergency Use Authorisation in the UK marks a historic moment in the fight against Covid-19," said Pfizer CEO Albert Bourla.
Britain on Wednesday became the first country in the world to approve the Pfizer-BioNTech COVID-19 vaccine for use and said that it will be rolled out from early next week.
A vaccine is seen as the best chance for the world to get back to some semblance of normality amid a global pandemic which has killed nearly 1.5 million people and upended the global economy.
"The government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech's COVID-19 vaccine for use," the government said.
Scientists at the University of Pennsylvania and the biotech firm Regeneron are investigating whether technology developed for gene therapy can be used to make a nasal spray that will prevent infection with the new coronavirus.
The idea is to use a weakened virus as a delivery truck to carry genetic instructions to cells within the nose and the throat, which will in turn create powerful antibodies to stop SARS-CoV-2 from invading our bodies.
"The advantage of our approach is that you don't need a competent immune system for this to be effective," James Wilson, a professor of medicine at Penn who is leading the project told AFP.
England on Wednesday exited a month-long lockdown but most of the country remained under restrictions as a new regional system for cutting coronavirus infection rates kicked in.
The four-week lockdown, which began in November, was imposed to stop surging rates of infection, ease pressure on health services, and to allow families to gather for Christmas.
But a tough three-tier system of restrictions will now be in place that has been criticised as doing little to reinstate cherished freedoms and help the virus-battered economy.
Most of England's 55 million people will go straight into level two or three, depending on local infection rates, limiting household mixing and the reopening of the hospitality sector.